Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H24N4O2 |
InChIKeyNYQHEGVGLCCWEM-UHFFFAOYSA-N |
CAS Registry1031977-31-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | CN | 28 Jun 2023 |